Evidence map›Paper›PMID 39528570›Full record

ArticleNature computational science2024

MassiveFold: unveiling AlphaFold's hidden potential with optimized and parallelized massive sampling.

Nessim Raouraoua, Claudio Mirabello, Thibaut Véry, Christophe Blanchet, Björn Wallner, Marc F Lensink, Guillaume Brysbaert

Abstract read
In one paragraph

Article in Nature computational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nessim RaouraouaUniversité de Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, CNRS, Lille, France.ORCID http://orcid.org/0009-0005-5652-684X
Claudio MirabelloScience for Life Laboratory, Department of Physics, Chemistry and Biology, National Bioinformatics Infrastructure Sweden, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0001-7868-034X
Thibaut VéryInstitut du Développement et des Ressources en Informatique Scientifique (IDRIS), CNRS, Université Paris-Saclay, Orsay, France.
Christophe BlanchetIFB-core, Institut Français de Bioinformatique (IFB), CNRS, INSERM, INRAE, CEA, Evry, France.
Björn WallnerDivision of Bioinformatics, Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0002-3772-8279
Marc F LensinkUniversité de Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, CNRS, Lille, France.ORCID http://orcid.org/0000-0003-3957-9470
Guillaume BrysbaertUniversité de Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille, CNRS, Lille, France. guillaume.brysbaert@univ-lille.fr.ORCID http://orcid.org/0000-0002-6807-6621

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Massive sampling in AlphaFold enables access to increased structural diversity. In combination with its efficient confidence ranking, this unlocks elevated modeling capabilities for monomeric structures and foremost for protein assemblies. However, the approach struggles with GPU cost and data storage. Here we introduce MassiveFold, an optimized and customizable version of AlphaFold that runs predictions in parallel, reducing the computing time from several months to hours. MassiveFold is scalable and able to run on anything from a single computer to a large GPU infrastructure, where it can fully benefit from all the computing nodes.

Identifiers

PMID39528570
PMCPMC11578886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.